<DOC>
	<DOCNO>NCT01238458</DOCNO>
	<brief_summary>This study recruit total 150 evaluable subject ( 30 cognitively normal volunteer , 60 MCI ( Mild cognitive impairment ) , 60 AD ( Alzheimer 's disease ) , respectively ) Each evaluable subject involve study must fulfill inclusion exclusion criterion accord subject grouping . Safety measurement evaluate medical history , vital sign , physical examination , laboratory examination collect adverse event . This study expect completed period 3 year .</brief_summary>
	<brief_title>Phase II Study Amyloid Binding Imaging Study 18FAV-45 Patients With Mild Cognitive Impairment , Alzheimer 's Disease Healthy Volunteers</brief_title>
	<detailed_description>The primary objective protocol address feasibility clinical utilization [ 18F ] AV-45 various neurodegenerative disease . Specifically , expand database [ 18F ] AV-45 PET image Alzheimer 's disease MCI patient refine definition positive scan patient AD MCI compare healthy control . Secondary , expand safety database [ 18F ] AV-45 PET image . In addition , image characteristic prevalence Aß positivity evaluate different subset MCI AD patient .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Both gender ≥ 50 year old . Written date informed consent self legal representative , obtain study procedure . 30 cognitively normal volunteer evidence significant cognitive impairment history psychometrictesting ( MMSE &gt; 24 ) . 60 subject diagnosis AD accord NINCDSADRDA criterion . 60 subject diagnosis MCI 1 . Pregnant become pregnant study ( documented pregnancy test screen date study accord PI discretion ) current breast feeding . 2 . Modified Hachinski ischemic score &gt; 4 meet NINDSAIREN criterion vascular dementia . 3 . Any subject clinically significant abnormal laboratory value , and/or clinically significant unstable medical psychiatric illness . Clinically significant hepatic , renal , pulmonary , metabolic , endocrine disturbance , especially thyroid disease ; Current clinically significant cardiovascular disease . Clinically significant cardiovascular disease usually include one following : cardiac surgery myocardial infarction within last 6 month ; unstable angina coronary artery disease require change medication within last 3 month decompensated congestive heart failure significant cardiac arrhythmia conduction disturbance , particularly result atrial ventricular fibrillation , cause syncope , near syncope , alteration mental status severe mitral aortic valvular disease uncontrolled high blood pressure congenital heart disease clinically significant abnormal result ECG , include limited QTc &gt; 450 msec iii . Clinically significant infectious disease , include AIDS HIV infection active hepatitis B , active hepatitis C , HIV1 , HIV2 4 . History drug alcohol abuse within last year , prior prolonged history abuse . 5 . Patients evidence neurodegenerative disorder AD , cognitive impairment result trauma brain damage , brain infarction , clinically significant psychiatric disease , epilepsy , exclude .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>[ 18F ] AV-45 PET amyloid bind image</keyword>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>mild cognitive impartment ,</keyword>
</DOC>